{"product_id":"kirks-current-veterinary-therapy-xv-hardback-9781437726893","title":"Kirk's Current Veterinary Therapy XV (Hardback) 9781437726893","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eKirk's Current Veterinary Therapy XV\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eUse the latest practices and procedures in managing small animal disorders\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJohn D. Bonagura (Author), David C. Twedt (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781437726893\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 30 January 2014\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1456 pages, 365 illustrations\u003cbr\u003e27.6 x 21.6 x 6.3 cm, 3.13 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"For the practitioner who wants to keep abreast of current therapies for a wide range of topics, but cannot ?nd the time to read journals or attend conferences, CVT is the perfect reference for this very purpose.\"\u003c\/i\u003e\u003cb\u003e Reviewed by: \u003c\/b\u003eRyan Ong, WAVES Veterinary Hospital on behalf of Australian Veterinary Hospital, March 2015\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eWritten by today?s leading experts, Kirk's Current Veterinary Therapy, Volume XV keeps you completely current with the latest in disease management for dogs and cats. It uses a clear and practical approach to medical disorders; the typical chapter includes both a brief guide to diagnosis and a detailed discussion of therapy. You?ll gain quick access to information such as critical care; infectious, toxicologic, and dermatologic disorders; and diseases of the gastrointestinal, cardiovascular, respiratory, urinary, reproductive, neurologic,and ophthalmologic systems. From editors John Bonagura and David Twedt plus hundreds of expert contributors, Kirk's Current Veterinary Therapy enhances your skills in evidence-based treatment planning.\u003c\/p\u003e  \u003cp\u003e\u003ci\u003e\"For the practitioner who wants to keep abreast of current therapies for a wide range of topics, … CVT is the perfect reference .\"\u003c\/i\u003e \u003cb\u003eReviewed by:\u003c\/b\u003e Ryan Ong, WAVES Veterinary Hospital on behalf of Australian Veterinary Hospital, March 2015\u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eAuthoritative, easy-to-read coverage \u003c\/li\u003e\u003c\/b\u003eincludes a brief approach to diagnosis with detailed discussions of the latest therapies. \u003cli\u003e\n\u003cb\u003eAn organ-system organization\u003c\/b\u003e \u003cb\u003eand a convenient index\u003c\/b\u003e make it easy to find solutions for specific disorders.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eTreatment algorithms\u003c\/b\u003e help you manage patients with difficult medical problems.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eA handy \u003ci\u003eTable of Common Drugs\u003c\/i\u003e\u003c\/b\u003e, updated by Dr. Mark Papich, offers a quick reference to dosage information.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003e365 illustrations\u003c\/b\u003e depict the pathophysiologic basis for therapy or show the management of a defined condition. \u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eA companion website \u003c\/b\u003eincludes valuable information still relevant from \u003ci\u003eCVT XIV\u003c\/i\u003e, an index, and drug formulary, all fully searchable; a collection of 300 images; references that link to \u003ci\u003ePubMed\u003c\/i\u003e; and clinical references on laboratory test procedures and interpretation, normal reference ranges, conversion tables, and more.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eConcise chapters\u003c\/b\u003e are only 2-5 pages in length, saving you time in finding essential information.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eExpert contributors and editors\u003c\/b\u003e provide scientific, up-to-date coverage of clinically useful topics, including broad, traditional, and controversial subjects.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eReferences \u003c\/b\u003eindicate related material from earlier volumes of\u003cb\u003e \u003c\/b\u003e\u003ci\u003eKirk’s Current Veterinary Therapy\u003c\/i\u003e.\u003c\/li\u003e \u003c\/ul\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eNEW chapters\u003c\/li\u003e\u003c\/b\u003e cover the most important, emerging information on current diagnostic, treatment, and preventive challenges in today’s veterinary practice.  \u003cli\u003e\n\u003cb\u003eA new section on feline and canine nutrition\u003c\/b\u003e covers important issues in nutritional health. \u003c\/li\u003e \u003cli\u003e\n\u003cb\u003e50 new chapter authors\u003c\/b\u003e join hundreds of expert international contributors, all of whom\u003cb\u003e \u003c\/b\u003eare leading authorities in their fields.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW! Availability as Pageburst ebook\u003c\/b\u003e allows you digital access to this volume along with your library of other Elsevier references.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eSection I: Critical Care\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. Crystalloid Fluid Therapy\u003c\/p\u003e \u003cp\u003e2. Colloid Fluid Therapy\u003c\/p\u003e \u003cp\u003e3. Catecholamines in the Critical Care Patient\u003c\/p\u003e \u003cp\u003e4. Shock\u003c\/p\u003e \u003cp\u003e5. Cardiopulmonary Resuscitation\u003c\/p\u003e \u003cp\u003e6. Drug Incompatibilities and Drug-Drug Interactions in the ICU Patient\u003c\/p\u003e \u003cp\u003e7. Nutrition in Critical Care\u003c\/p\u003e \u003cp\u003e8. Stabilization of the Patient with Respiratory Distress\u003c\/p\u003e \u003cp\u003e9. Acute Respiratory Distress Syndrome\u003c\/p\u003e \u003cp\u003e10. Oxygen Therapy\u003c\/p\u003e \u003cp\u003e11. Ventilator Therapy for the Critical Patient\u003c\/p\u003e \u003cp\u003e12. Analgesia of the Critical Patient\u003c\/p\u003e \u003cp\u003e13. Anesthesia for the Critical Care Patient\u003c\/p\u003e \u003cp\u003e14. Hyperthermia and Heat-Induced Illness\u003c\/p\u003e \u003cp\u003e15. Thromboelastography\u003c\/p\u003e \u003cp\u003e16. Critical Illness-Related Corticosteroid Insufficiency \u003c\/p\u003e \u003cp\u003e17. Evaluation of Canine Orthopedic Trauma\u003c\/p\u003e \u003cp\u003e18. Emergency Management of Open Fractures\u003c\/p\u003e \u003cp\u003e19. Emergency Wound Management and Vacuum Assisted Wound Closure\u003c\/p\u003e \u003cp\u003eWeb Chapter 1. Acid-Base Disorders\u003c\/p\u003e \u003cp\u003eWeb Chapter 2. Drainage Techniques for the Septic Abdomen\u003c\/p\u003e \u003cp\u003eWeb Chapter 3. Gastric Dilation-Volvulus\u003c\/p\u003e \u003cp\u003eWeb Chapter 4. Pacing in the ICU Setting\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection II: Toxicologic Diseases\u003c\/p\u003e \u003cp\u003e20. ASPCA Animal Poison Center Toxin Exposures for Pets\u003c\/p\u003e \u003cp\u003e21. Toxin Exposures in Small Animals\u003c\/p\u003e \u003cp\u003e22. Urban Legends of Toxicology: Fact and Fiction\u003c\/p\u003e \u003cp\u003e23. Drugs Used to Treat Toxicoses\u003c\/p\u003e \u003cp\u003e24. Intravenous Lipid Emulsion Therapy\u003c\/p\u003e \u003cp\u003e25. Human Drugs of Abuse and CNS Stimulants\u003c\/p\u003e \u003cp\u003e26. Antidepressants and anxiolytics\u003c\/p\u003e \u003cp\u003e27. Over-the-Counter Drug Toxicosis\u003c\/p\u003e \u003cp\u003e28. Top 10 Toxic and Non-Toxic Household Plants \u003c\/p\u003e \u003cp\u003e29. Herbal Hazards\u003c\/p\u003e \u003cp\u003e30. Lawn and Garden Product Safety \u003c\/p\u003e \u003cp\u003e31. Rodenticide Toxicoses\u003c\/p\u003e \u003cp\u003e32. Insecticide Toxicoses\u003c\/p\u003e \u003cp\u003e33. Pesticides: New Vertebrate Toxic Agents for Pest Species\u003c\/p\u003e \u003cp\u003e34. Parasiticide Toxicoses: Avermectins\u003c\/p\u003e \u003cp\u003e35. Human Foods with Pet Toxicoses: Alcohol to Xylitol\u003c\/p\u003e \u003cp\u003e36. Automotive Toxins\u003c\/p\u003e \u003cp\u003e37. Lead Toxicoses in Small Animals\u003c\/p\u003e \u003cp\u003e38. Aflatoxicosis in Dogs\u003c\/p\u003e \u003cp\u003eWeb Chapter 5. Nephrotoxicants\u003c\/p\u003e \u003cp\u003eWeb Chapter 6. Reporting Adverse Events to the Food and Drug Administration – Center for Veterinary Medicine\u003c\/p\u003e \u003cp\u003eWeb Chapter 7. Respiratory Toxicants of Interest to Pet Owners \u003c\/p\u003e \u003cp\u003eWeb Chapter 8. Small Animal Poisoning: Additional Considerations Related to Legal Claims\u003c\/p\u003e \u003cp\u003eWeb Chapter 9. Sources of Help for Toxicoses\u003c\/p\u003e \u003cp\u003eWeb Chapter 10. Treatment of Animal Toxicoses: Regulatory Points to Consider\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection III: Endocrine and Metabolic Diseases\u003c\/p\u003e \u003cp\u003e39. Bilaterally Symmetrical Alopecia in Dogs\u003c\/p\u003e \u003cp\u003e40. Imaging in Diagnosis of Endocrine Disorders\u003c\/p\u003e \u003cp\u003e41. CIRCI: Evidence For and Against\u003c\/p\u003e \u003cp\u003e42. Canine Hypothyroidism\u003c\/p\u003e \u003cp\u003e43. Feline Hyperthyroidism and Renal Function\u003c\/p\u003e \u003cp\u003e44. Canine Diabetes Mellitus\u003c\/p\u003e \u003cp\u003e45. Diabetic Monitoring\u003c\/p\u003e \u003cp\u003e46. Diet and Diabetes\u003c\/p\u003e \u003cp\u003e47. Insulin Resistance\u003c\/p\u003e \u003cp\u003e48. Feline Diabetes Mellitus\u003c\/p\u003e \u003cp\u003e49. Feline Hypersomatotropism and Acromegaly\u003c\/p\u003e \u003cp\u003e50. Occult Hyperadrenocorticism: Is It Real?\u003c\/p\u003e \u003cp\u003e51. Canine Hyperadrenocorticism Therapy\u003c\/p\u003e \u003cp\u003e52. Ectopic Acth Syndrome and Food-Dependent Hypercortisolism In Dogs\u003c\/p\u003e \u003cp\u003e53. Canine Hypoadrenocorticism\u003c\/p\u003e \u003cp\u003e54. Feline Hyperaldosteronism\u003c\/p\u003e \u003cp\u003e55. Idiopathic Feline Hypercalcemia\u003c\/p\u003e \u003cp\u003e56. Approach to Hypomagnesemia and Hypokalemia\u003c\/p\u003e \u003cp\u003e57. Obesity\u003c\/p\u003e \u003cp\u003e58. Approach to Hyperlipidemia\u003c\/p\u003e \u003cp\u003eWeb Chapter 11. Canine Hypercalcemia and Primary Hyperparathyroidism\u003c\/p\u003e \u003cp\u003eWeb Chapter 12. Clinical Use of the Vasopressin Analogue Desmopressin for the Diagnosis and Treatment of Diabetes Insipidus\u003c\/p\u003e \u003cp\u003eWeb Chapter 13. Complicated Diabetes Mellitus\u003c\/p\u003e \u003cp\u003eWeb Chapter 14. Complications and Concurrent Conditions Associated with Hypothyroidism in Dogs\u003c\/p\u003e \u003cp\u003eWeb Chapter 15. Diagnosis and Management of Large Pituitary Tumors in Dogs with Pituitary-Dependent Hyperadrenocorticism\u003c\/p\u003e \u003cp\u003eWeb Chapter 16. Differential Diagnosis of Hyperkalemia and Hyponatremia in Dogs and Cats\u003c\/p\u003e \u003cp\u003eWeb Chapter 17. Hyperadrenocorticism in Ferrets\u003c\/p\u003e \u003cp\u003eWeb Chapter 18. Interpretation of Endocrine Diagnostic Tests\u003c\/p\u003e \u003cp\u003eWeb Chapter 19. Medical Treatment of Feline Hyperthyroidism\u003c\/p\u003e \u003cp\u003eWeb Chapter 20. Nutritional Management of Feline Hyperthyroidism\u003c\/p\u003e \u003cp\u003eWeb Chapter 21. Radioiodine for Feline Hyperthyroidism\u003c\/p\u003e \u003cp\u003eWeb Chapter 22. Treatment of Hypoparathyroidism\u003c\/p\u003e \u003cp\u003eWeb Chapter 23. Treatment of Insulinoma in the Dog, Cat and Ferret\u003c\/p\u003e \u003cp\u003eWeb Chapter 24. Treatment of Non-Insulin Dependent Diabetes Mellitus in Cats Using Oral Hypoglycemic Agents\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection IV: Oncology and Hematology\u003c\/p\u003e \u003cp\u003e59. Immunosuppressive Agents\u003c\/p\u003e \u003cp\u003e60. Management of Immune Mediated Hemolytic Anemia in Dogs\u003c\/p\u003e \u003cp\u003e61. Thrombocytopenia\u003c\/p\u003e \u003cp\u003e62. von Willebrand's Disease and Other Hereditary Coagulopathies\u003c\/p\u003e \u003cp\u003e63. Disseminated Intravascular Coagulation: Diagnosis and Management\u003c\/p\u003e \u003cp\u003e64. Hypercoagulable States\u003c\/p\u003e \u003cp\u003e65. Lymphocytosis\u003c\/p\u003e \u003cp\u003e66. Quality Control for the In-Clinic Laboratory\u003c\/p\u003e \u003cp\u003e67. Transfusion Medicine: Best Practices\u003c\/p\u003e \u003cp\u003e68. Bone Marrow Dyscrasias\u003c\/p\u003e \u003cp\u003e69. Anticancer Drugs: New Drugs\u003c\/p\u003e \u003cp\u003e70. Tumor Biopsy and Specimen Submission\u003c\/p\u003e \u003cp\u003e71. Chemotherapy Handling and Safety\u003c\/p\u003e \u003cp\u003e72. Treatment of Adverse Effects from Cancer Therapy\u003c\/p\u003e \u003cp\u003e73. Cancer Immunotherapy\u003c\/p\u003e \u003cp\u003e74. Advances in Radiation Therapy for Nasal Tumors\u003c\/p\u003e \u003cp\u003e75. Malignant Effusions\u003c\/p\u003e \u003cp\u003e76. Interventional Oncology\u003c\/p\u003e \u003cp\u003e77. Nutritional Support of the Cancer Patient\u003c\/p\u003e \u003cp\u003e78. Metronomic Chemotherapy\u003c\/p\u003e \u003cp\u003e79. Drug Update: Toceranib\u003c\/p\u003e \u003cp\u003e80. Drug Update: Masitinib\u003c\/p\u003e \u003cp\u003e81. Oral Tumors\u003c\/p\u003e \u003cp\u003e82. Perineal Tumors\u003c\/p\u003e \u003cp\u003e83. Urinary Bladder Cancer\u003c\/p\u003e \u003cp\u003e84. Mammary Cancer\u003c\/p\u003e \u003cp\u003e85. Rescue Therapy for Canine Lymphoma\u003c\/p\u003e \u003cp\u003e86. Plasma Cell Neoplasms\u003c\/p\u003e \u003cp\u003e87. Osteosarcoma\u003c\/p\u003e \u003cp\u003e88. Hemangiosarcoma\u003c\/p\u003e \u003cp\u003e89. Thyroid Tumors\u003c\/p\u003e \u003cp\u003eWeb Chapter 25. Anticancer Drugs: New Drugs\u003c\/p\u003e \u003cp\u003eWeb Chapter 26. Blood Typing and Crossmatching\u003c\/p\u003e \u003cp\u003eWeb Chapter 27. Canine Soft-Tissue Sarcomas\u003c\/p\u003e \u003cp\u003eWeb Chapter 28. Collection of Specimens for Cytology\u003c\/p\u003e \u003cp\u003eWeb Chapter 29. Nasal Tumors\u003c\/p\u003e \u003cp\u003eWeb Chapter 30. Nonregenerative Anemias\u003c\/p\u003e \u003cp\u003eWeb Chapter 31. Pulmonary Neoplasia\u003c\/p\u003e \u003cp\u003eWeb Chapter 32. Surgical Oncology Principles\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection V: Dermatologic Diseases\u003c\/p\u003e \u003cp\u003e90. Diagnostic Criteria for Canine Atopic Dermatitis\u003c\/p\u003e \u003cp\u003e91. Treatment Guidelines for Canine Atopic Dermatitis\u003c\/p\u003e \u003cp\u003e92. Cyclosporine Use in Dermatology\u003c\/p\u003e \u003cp\u003e93. Allergen-Specific Immunotherapy\u003c\/p\u003e \u003cp\u003e94. Systemic Glucocorticoids in Dermatology\u003c\/p\u003e \u003cp\u003e95. Topical Therapy for Pruritus\u003c\/p\u003e \u003cp\u003e96. Hypoallergenic Diets: Principles in Therapy\u003c\/p\u003e \u003cp\u003e97. Flea Control in Flea Allergy Dermatitis\u003c\/p\u003e \u003cp\u003e98. Treatment of Ectoparasitoses\u003c\/p\u003e \u003cp\u003e99. Canine Demodicosis\u003c\/p\u003e \u003cp\u003e100. Staphylococci Causing Pyoderma\u003c\/p\u003e \u003cp\u003e101. Treatment of Superficial Pyoderma\u003c\/p\u003e \u003cp\u003e102. Topical Therapy for Infectious Diseases\u003c\/p\u003e \u003cp\u003e103. Methicillin-Resistant Staphylococcal Infections\u003c\/p\u003e \u003cp\u003e104. Canine Leproid Granulma Syndrome and Feline Leprosy\u003c\/p\u003e \u003cp\u003e105. Dermatophytosis\u003c\/p\u003e \u003cp\u003e106. Dermatophytosis in Catteries and Shelters\u003c\/p\u003e \u003cp\u003e107. Hospital Disinfection for Infectious Skin Diseases\u003c\/p\u003e \u003cp\u003e108. Principles of Therapy for Otitis\u003c\/p\u003e \u003cp\u003e109. Topical and Systemic Glucocorticoids for Otitis\u003c\/p\u003e \u003cp\u003e110. Topical Antimicrobials for Otitis\u003c\/p\u003e \u003cp\u003e111. Systemic Antimicrobials for Otitis\u003c\/p\u003e \u003cp\u003e112. Ototoxicity\u003c\/p\u003e \u003cp\u003e113. Ear Flushing Techniques\u003c\/p\u003e \u003cp\u003e114. Primary Cornification Disorders In Dogs\u003c\/p\u003e \u003cp\u003e115. Alopecia X\u003c\/p\u003e \u003cp\u003e116. Actinic Dermatoses and Sun Protection\u003c\/p\u003e \u003cp\u003e117. Drugs for Behavior-Related Dermatoses\u003c\/p\u003e \u003cp\u003e118. Superficial Necrolytic Dermatitis\u003c\/p\u003e \u003cp\u003e119. Cutaneous Adverse Drug Reactions (CADR)\u003c\/p\u003e \u003cp\u003eWeb Chapter 33. Acral Lick Dermatitis\u003c\/p\u003e \u003cp\u003eWeb Chapter 34. Avermectins in Dermatology\u003c\/p\u003e \u003cp\u003eWeb Chapter 35. Canine Papilloma Viruses\u003c\/p\u003e \u003cp\u003eWeb Chapter 36. Diseases of the Anal Sac\u003c\/p\u003e \u003cp\u003eWeb Chapter 37. Feline Demodicosis\u003c\/p\u003e \u003cp\u003eWeb Chapter 38. Feline Viral Skin Diseases\u003c\/p\u003e \u003cp\u003eWeb Chapter 39. House Dust Mites and Their Control\u003c\/p\u003e \u003cp\u003eWeb Chapter 40. Interferons\u003c\/p\u003e \u003cp\u003eWeb Chapter 41. Pentoxifylline\u003c\/p\u003e \u003cp\u003eWeb Chapter 42. Pyotraumatic Dermatitis\u003c\/p\u003e \u003cp\u003eWeb Chapter 43. Sebaceous Adenitis\u003c\/p\u003e \u003cp\u003eWeb Chapter 44. Therapy of Malassezia Infections\u003c\/p\u003e \u003cp\u003eWeb Chapter 45. Topical Immunomodulators\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection VI: Gastrointestinal Diseases\u003c\/p\u003e \u003cp\u003e120. Feline Caudal Stomatitis\u003c\/p\u003e \u003cp\u003e121. Oropharyngeal Dysphagia\u003c\/p\u003e \u003cp\u003e122. Gastroesophageal Reflux\u003c\/p\u003e \u003cp\u003e123. Antacid Therapy\u003c\/p\u003e \u003cp\u003e124. Gastric Helicobacter\u003c\/p\u003e \u003cp\u003e125. Diagnosis and Treatment of Motility Disorders\u003c\/p\u003e \u003cp\u003e126. Antibiotic Responsive Enteropathy\u003c\/p\u003e \u003cp\u003e127. Cobalamin Deficiency in Cats\u003c\/p\u003e \u003cp\u003e128. Probiotic Therapy\u003c\/p\u003e \u003cp\u003e129. Protozoal Diarrhea\u003c\/p\u003e \u003cp\u003e130. Diagnosis and Treatment of Canine Parvoviral Enteritis\u003c\/p\u003e \u003cp\u003e131. Inflammatory Bowel Disease\u003c\/p\u003e \u003cp\u003e132. Protein Losing Enteropathy\u003c\/p\u003e \u003cp\u003e133. Feline Gastrointestinal Lymphoma\u003c\/p\u003e \u003cp\u003e134. Management of Canine Colitis\u003c\/p\u003e \u003cp\u003e135. Laboratory Testing for the Exocrine Pancreas\u003c\/p\u003e \u003cp\u003e136. Exocrine Pancreatic Insufficiency in Dogs\u003c\/p\u003e \u003cp\u003e137. Treatment of Canine Pancreatitis\u003c\/p\u003e \u003cp\u003e138. Feline Exocrine Pancreatic Disorders\u003c\/p\u003e \u003cp\u003e139. Diagnostic Approach to Hepatobiliary Disease\u003c\/p\u003e \u003cp\u003e140. Drug Associated Liver Disease\u003c\/p\u003e \u003cp\u003e141. Acute Liver Failure Therapy\u003c\/p\u003e \u003cp\u003e142. Chronic Hepatitis Therapy\u003c\/p\u003e \u003cp\u003e143. Copper Chelator Therapy\u003c\/p\u003e \u003cp\u003e144. Ascites and Hepatic Encephalopathy Therapy for Liver Disease\u003c\/p\u003e \u003cp\u003e145. Portosystemic Shunts\u003c\/p\u003e \u003cp\u003e146. Portal Vein Hypoplasia (Microvascular Dysplasia)\u003c\/p\u003e \u003cp\u003e147. Management of Extrahepatic Biliary Tract Disease\u003c\/p\u003e \u003cp\u003e148. Idiopathic Vacuolar Hepatopathy\u003c\/p\u003e \u003cp\u003e149. Feline Hepatic Lipidosis Therapy\u003c\/p\u003e \u003cp\u003e150. Feline Inflammatory Liver Disease\u003c\/p\u003e \u003cp\u003eWeb Chapter 46. Canine Biliary Mucocele\u003c\/p\u003e \u003cp\u003eWeb Chapter 47. Canine Megaesophagus\u003c\/p\u003e \u003cp\u003eWeb Chapter 48. Copper Associated Chronic Hepatitis\u003c\/p\u003e \u003cp\u003eWeb Chapter 49. Esophagitis\u003c\/p\u003e \u003cp\u003eWeb Chapter 50. Evaluation of Elevated Serum Alkaline Phosphatase in Dogs\u003c\/p\u003e \u003cp\u003eWeb Chapter 51. Flatulence\u003c\/p\u003e \u003cp\u003eWeb Chapter 52. Gastric Ulceration\u003c\/p\u003e \u003cp\u003eWeb Chapter 53. Hepatic Support Therapy\u003c\/p\u003e \u003cp\u003eWeb Chapter 54. Oral Pharyngeal Dysphagia\u003c\/p\u003e \u003cp\u003eWeb Chapter 55. Tylosin Responsive Diarrhea\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection VII: Respiratory Diseases\u003c\/p\u003e \u003cp\u003e151. Respiratory Drug Therapy\u003c\/p\u003e \u003cp\u003e152. Feline Upper Respiratory Tract Infection\u003c\/p\u003e \u003cp\u003e153. Canine Infectious Respiratory Disease Complex\u003c\/p\u003e \u003cp\u003e154. Rhinitis in the Dog\u003c\/p\u003e \u003cp\u003e155. Rhinitis in the Cat\u003c\/p\u003e \u003cp\u003e156. Brachycephalic Airway Obstruction Syndrome\u003c\/p\u003e \u003cp\u003e157. Nasopharyngeal Disorders\u003c\/p\u003e \u003cp\u003e158. Laryngeal Diseases\u003c\/p\u003e \u003cp\u003e159. Tracheal Collapse\u003c\/p\u003e \u003cp\u003e160. Chronic Bronchial Disorders in the Dog\u003c\/p\u003e \u003cp\u003e161. Chronic Bronchitis and Asthma in Cats\u003c\/p\u003e \u003cp\u003e162. Pneumonia\u003c\/p\u003e \u003cp\u003e163. Eosinophilic Pulmonary Diseases\u003c\/p\u003e \u003cp\u003e164. Pleural Effusion\u003c\/p\u003e \u003cp\u003e165. Pneumothorax\u003c\/p\u003e \u003cp\u003e166. Pulmonary Thromboembolism\u003c\/p\u003e \u003cp\u003e167. Pulmonary Hypertension\u003c\/p\u003e \u003cp\u003eWeb Chapter 56. Interstitial Lung Diseases\u003c\/p\u003e \u003cp\u003eWeb Chapter 57. Respiratory Parasites\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection VIII: Cardiovascular Diseases\u003c\/p\u003e \u003cp\u003e168. Nutritional Management of Heart Disease\u003c\/p\u003e \u003cp\u003e169. Systemic Hypertension\u003c\/p\u003e \u003cp\u003e170. Bradyarrhythmias\u003c\/p\u003e \u003cp\u003e171. Supraventricular Tachyarrhythmias in Dogs\u003c\/p\u003e \u003cp\u003e172. Ventricular Arrhythmias in Dogs\u003c\/p\u003e \u003cp\u003e173. Feline Cardiac Arrhythmias\u003c\/p\u003e \u003cp\u003e174. Congenital Heart Disease\u003c\/p\u003e \u003cp\u003e175. Drugs for Treatment of Heart Failure\u003c\/p\u003e \u003cp\u003e176. Management of Heart Failure in Dogs\u003c\/p\u003e \u003cp\u003e177. Chronic Valvular Heart Disease in Dogs\u003c\/p\u003e \u003cp\u003e178. Dilated Cardiomyopathy in Dogs\u003c\/p\u003e \u003cp\u003e179. Arrhythmogenic Right Ventricular Cardiomyopathy\u003c\/p\u003e \u003cp\u003e180. Feline Myocardial Diseases\u003c\/p\u003e \u003cp\u003e181. Arterial Thromboembolism\u003c\/p\u003e \u003cp\u003e182. Pericardial Effusion\u003c\/p\u003e \u003cp\u003e183. Feline Heartworm Disease\u003c\/p\u003e \u003cp\u003e184. Canine Heartworm Disease\u003c\/p\u003e \u003cp\u003eWeb Chapter 58. Arrhythmogenic Right Ventricular Cardiomyopathy in the Cat\u003c\/p\u003e \u003cp\u003eWeb Chapter 59. Bradyarrhythmias and Cardiac Pacing\u003c\/p\u003e \u003cp\u003eWeb Chapter 60. Cardioversion\u003c\/p\u003e \u003cp\u003eWeb Chapter 61. Infective Endocarditis\u003c\/p\u003e \u003cp\u003eWeb Chapter 62. Mitral Valve Dysplasia\u003c\/p\u003e \u003cp\u003eWeb Chapter 63. Myocarditis\u003c\/p\u003e \u003cp\u003eWeb Chapter 64. Patent Ductus Arteriosus\u003c\/p\u003e \u003cp\u003eWeb Chapter 65. Pulmonic Stenosis\u003c\/p\u003e \u003cp\u003eWeb Chapter 66. Subaortic Stenosis\u003c\/p\u003e \u003cp\u003eWeb Chapter 67. Syncope\u003c\/p\u003e \u003cp\u003eWeb Chapter 68. Tricuspid Valve Dysplasia\u003c\/p\u003e \u003cp\u003eWeb Chapter 69. Ventricular Septal Defect\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection IX: Urinary Diseases\u003c\/p\u003e \u003cp\u003e185. Applicatioins of Ultrasound in Diagnosis and Management of Urinary Disease\u003c\/p\u003e \u003cp\u003e186. Prevention and Management of AKI\/ARF in the Hospital\u003c\/p\u003e \u003cp\u003e187. Proteinuria\u003c\/p\u003e \u003cp\u003e188. Glomerular Disease and Nephrotic Syndrome\u003c\/p\u003e \u003cp\u003e189. Chronic Kidney Disease in Dogs and Cats\u003c\/p\u003e \u003cp\u003e190. Using NSAIDS in Kidney Disease\u003c\/p\u003e \u003cp\u003e191. Medical Management of Acute Kidney Injury\/ARF\u003c\/p\u003e \u003cp\u003e192. CRRT\u003c\/p\u003e \u003cp\u003e193. Surveillance for Asymptomatic and Hospital Acquired UTI\u003c\/p\u003e \u003cp\u003e194. Persistent E. coli UTI\u003c\/p\u003e \u003cp\u003e195. Interventional Strategies for Urinary Disease\u003c\/p\u003e \u003cp\u003e196. Medical Management for Nephroliths and Ureteroliths\u003c\/p\u003e \u003cp\u003e197. Management of Calcium Oxalate Uroliths\u003c\/p\u003e \u003cp\u003e198. Management of Urate Urolithiasis\u003c\/p\u003e \u003cp\u003e199. Mini-Laparotomy Assisted Cystoscopy for Cystouroliths\u003c\/p\u003e \u003cp\u003e200. Multimodal Environmental Enrichment for FIC\u003c\/p\u003e \u003cp\u003e201. Urinary Incontinence – Medical Management\u003c\/p\u003e \u003cp\u003e202. Mechanical Occluder Devices for Urinary Incontinence\u003c\/p\u003e \u003cp\u003e203. Top Ten Urology Consult Questions\u003c\/p\u003e \u003cp\u003eWeb Chapter 70. Laser Lithotripsy\u003c\/p\u003e \u003cp\u003eWeb Chapter 71. Urinary Incontinence – Bulking Agents\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection X: Reproductive Diseases\u003c\/p\u003e \u003cp\u003e204. Breeding Management of the Bitch\u003c\/p\u003e \u003cp\u003e205. Diagnosis of Female ReproductiveTract Disease\u003c\/p\u003e \u003cp\u003e206. Endoscopic Transcervical Insemination\u003c\/p\u003e \u003cp\u003e207. Pregnancy Diagnosis\u003c\/p\u003e \u003cp\u003e208. Dystocia Management\u003c\/p\u003e \u003cp\u003e209. Canine Postpartum Disorders\u003c\/p\u003e \u003cp\u003e210. Nutrition in the Bitch During Pregnancy and Lactation\u003c\/p\u003e \u003cp\u003e211. Pyometra\u003c\/p\u003e \u003cp\u003e212. Vaginitis\u003c\/p\u003e \u003cp\u003e213. Surgical Repair of Vaginal Anomalies in the Bitch\u003c\/p\u003e \u003cp\u003e214. Early Age Neutering in the Dog and Cat\u003c\/p\u003e \u003cp\u003e215. Estrus Suppression\u003c\/p\u003e \u003cp\u003e216. Pregnancy Termination\u003c\/p\u003e \u003cp\u003e217. Inherited Disorders of the Reproductive Tract in Dogs and Cats\u003c\/p\u003e \u003cp\u003e218. Ovarian Remnant Syndrome\u003c\/p\u003e \u003cp\u003e219. Pregnancy Loss in the Bitch and Queen\u003c\/p\u003e \u003cp\u003e220. Medical Treatment of Benign Prostatic Hypertrophy and Prostatitis in Dogs\u003c\/p\u003e \u003cp\u003e221. Methods and Availability of Tests for Hereditary Disorders of Dogs\u003c\/p\u003e \u003cp\u003e222. Reproductive Oncology\u003c\/p\u003e \u003cp\u003e223. Reproductive Toxicology\/Teratogens\u003c\/p\u003e \u003cp\u003e224. Penile, Preputial, Testicular or Scrotal Diseases\/Problems\u003c\/p\u003e \u003cp\u003eWeb Chapter 72. Aspermia\/Oligozoospermia Caused by Retrograde Ejaculation in the Dog\u003c\/p\u003e \u003cp\u003eWeb Chapter 73. Priapism in Dogs\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection XI: Neurologic and Musculoskeletal Diseases\u003c\/p\u003e \u003cp\u003e225. Congenital Hydrocelphalus\u003c\/p\u003e \u003cp\u003e226. Intracranial Arachnoid Cysts\u003c\/p\u003e \u003cp\u003e227. Treatment of Intracranial Tumors\u003c\/p\u003e \u003cp\u003e228. Metabolic Brain Disorders\u003c\/p\u003e \u003cp\u003e229. New Maintenance Anticonvulsant Therapy for Dogs and Cats\u003c\/p\u003e \u003cp\u003e230. Treatment of Cluster Seizures and Status Epilepticus\u003c\/p\u003e \u003cp\u003e231. Non-Infectious\/Inflammatory Diseases of the Central Nervous System\u003c\/p\u003e \u003cp\u003e232. Peripheral and Central Vestibular Disorders of Dogs and Cats\u003c\/p\u003e \u003cp\u003e233. Diagnosis and Treatment Degenerative Intervertebral Disk Disease\u003c\/p\u003e \u003cp\u003e234. Degenerative Myelopathy in Dogs\u003c\/p\u003e \u003cp\u003e235. Diagnosis and Treatment of Atlantoaxial Subluxation\u003c\/p\u003e \u003cp\u003e236. Diagnosis and Treatment of Cervical Spondylomyelopathy\u003c\/p\u003e \u003cp\u003e237. Craniocervical Junction Abnormalities in Dogs\u003c\/p\u003e \u003cp\u003e238. Diagnosis and Treatment of Degenerative Lumbosacral Stenosis\u003c\/p\u003e \u003cp\u003e239. Acquired Myasthenia Gravis in Dogs and Cats\u003c\/p\u003e \u003cp\u003e240. Peripheral Nervous System Disorders in Dogs and Cats: Selected Myopathies in Neuropathies\u003c\/p\u003e \u003cp\u003e241. Vascular Disease of the Central Nervous System\u003c\/p\u003e \u003cp\u003eWeb Chapter 74. Physical Therapy and Rehabilitation of Neurologic Patients\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection XII: Ophthalmologic Diseases\u003c\/p\u003e \u003cp\u003e242. Pearls of the Ophthalmic Examination\u003c\/p\u003e \u003cp\u003e243. Evaluation of Blindness\u003c\/p\u003e \u003cp\u003e244. Canine Conjunctivitis\u003c\/p\u003e \u003cp\u003e245. Tear Film Disorders of Dogs\u003c\/p\u003e \u003cp\u003e246. Corneal Ulcers\u003c\/p\u003e \u003cp\u003e247. Canine Non-Ulcerative Corneal Disease\u003c\/p\u003e \u003cp\u003e248. Feline Corneal Disease\u003c\/p\u003e \u003cp\u003e249. Canine Uveitis\u003c\/p\u003e \u003cp\u003e250. Feline Uveitis\u003c\/p\u003e \u003cp\u003e251. Canine Glaucoma\u003c\/p\u003e \u003cp\u003e252. Feline Glaucoma\u003c\/p\u003e \u003cp\u003e253. Disorders of the Lens\u003c\/p\u003e \u003cp\u003e254. Canine Retinopathies\u003c\/p\u003e \u003cp\u003e255. Feline Retinopathies\u003c\/p\u003e \u003cp\u003e256. Orbital Disease\u003c\/p\u003e \u003cp\u003e257. Canine Ocular Neoplasia\u003c\/p\u003e \u003cp\u003e258. Feline Ocular Neoplasia\u003c\/p\u003e \u003cp\u003eWeb Chapter 75. Diseases of the Eyelids and Periocular Skin\u003c\/p\u003e \u003cp\u003eWeb Chapter 76. Canine Retinal Detachment\u003c\/p\u003e \u003cp\u003eWeb Chapter 77. Epiphora\u003c\/p\u003e \u003cp\u003eWeb Chapter 78. Ocular Emergencies\u003c\/p\u003e \u003cp\u003eWeb Chapter 79. Tear Film Disorders of Cats\u003c\/p\u003e \u003cp\u003eWeb Chapter 80. Anisocoria and Abnormalties of the Pupillary Light Reflex: The Neuro-Ophthalmic Examination\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSection XIII: Infectious Diseases\u003c\/p\u003e \u003cp\u003e259. Common Infectious Disease Differentials for Medical Problems\u003c\/p\u003e \u003cp\u003e260. Empiric Antimicrobial Therapy\u003c\/p\u003e \u003cp\u003e261. Infectious and Immune Polyarthritis\u003c\/p\u003e \u003cp\u003e262. Use of Immunomodulators in the Treatment of Infectious Diseases\u003c\/p\u003e \u003cp\u003e263. Use of Antifungal Drugs\u003c\/p\u003e \u003cp\u003e264. Infectious Diseases Associated with Raw Meat Diets\u003c\/p\u003e \u003cp\u003e265. Pet Associated Illness\u003c\/p\u003e \u003cp\u003e266. Vaccine Associated Side-Effects in Dogs\u003c\/p\u003e \u003cp\u003e267. Vaccine Associated Side-Effects in Cats\u003c\/p\u003e \u003cp\u003e268. Babesiosis in North America\u003c\/p\u003e \u003cp\u003e269. Bartonellosis, Canine\u003c\/p\u003e \u003cp\u003e270. Bartonellosis, Feline\u003c\/p\u003e \u003cp\u003e271. Borreliosis\u003c\/p\u003e \u003cp\u003e272. Feline Leukemia Virus\/FIV\u003c\/p\u003e \u003cp\u003e273. Hepatozoon Americanum Infections\u003c\/p\u003e \u003cp\u003e274. Leptospirosis\u003c\/p\u003e \u003cp\u003e275. Neospora Caninum\u003c\/p\u003e \u003cp\u003e276. Rickettsia Infections in Dogs and Cats (Anaplasma, Ehrlichia and Rickettsia)\u003c\/p\u003e \u003cp\u003e277. Toxoplasmosis\u003c\/p\u003e \u003cp\u003e278. Use of Glucocorticoids in Infectious Diseases\u003c\/p\u003e \u003cp\u003e279. Feline Infectious Peritonitis\u003c\/p\u003e \u003cp\u003eWeb Chapter 80. American Leishmaniasis\u003c\/p\u003e \u003cp\u003eWeb Chapter 81. Canine and Feline Hemotropic Mycoplasmas\u003c\/p\u003e \u003cp\u003eWeb Chapter 82. Canine Brucellosis\u003c\/p\u003e \u003cp\u003eWeb Chapter 83. Cytauxzoonosis\u003c\/p\u003e \u003cp\u003eWeb Chapter 84. Pneumocytosis\u003c\/p\u003e \u003cp\u003eWeb Chapter 85. Pythiosis and Lagenidiosis\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Veterinary medicine: small animals [\u003ca title=\"See our other books on Veterinary medicine: small animals\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Veterinary%20medicine:%20small%20animals%20%5Bpets%5D%20%5BMZC%5D%22\"\u003epets MZC\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648227397912,"sku":"9781437726893","price":84.98,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781437726893.jpg?v=1696743619","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/kirks-current-veterinary-therapy-xv-hardback-9781437726893","provider":"Freshly Printed Books","version":"1.0","type":"link"}